BioLargo, Inc.
BLGO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $57 | $48 | $52 | $52 |
| - Cash | $4 | $4 | $2 | $1 |
| + Debt | $3 | $2 | $1 | $1 |
| Enterprise Value | $56 | $46 | $52 | $52 |
| Revenue | $18 | $12 | $6 | $3 |
| % Growth | 45.4% | 107.9% | 132.5% | – |
| Gross Profit | $8 | $6 | $3 | $1 |
| % Margin | 44.2% | 50.3% | 48.6% | 43.6% |
| EBITDA | -$4 | -$4 | -$5 | -$7 |
| % Margin | -22.8% | -34.2% | -86.6% | -264.8% |
| Net Income | -$2 | -$4 | -$4 | -$7 |
| % Margin | -13.5% | -28.7% | -76.4% | -291.5% |
| EPS Diluted | -0.008 | -0.012 | -0.017 | -0.03 |
| % Growth | 34.1% | 26.8% | 43.6% | – |
| Operating Cash Flow | -$3 | -$2 | -$3 | -$4 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$3 | -$3 | -$4 |